APA (7th ed.) Citation

Chen, Q. W., Cai, Q. Q., Yang, Y., Dong, S., Liu, Y. Y., Chen, Z. Y., . . . Wu, X. Z. (2023). LncRNA BC promotes lung adenocarcinoma progression by modulating IMPAD1 alternative splicing. Clinical & Translational Medicine, 13(1), 1. https://doi.org/10.1002/ctm2.1129

Chicago Style (17th ed.) Citation

Chen, Qi Wen, et al. "LncRNA BC Promotes Lung Adenocarcinoma Progression by Modulating IMPAD1 Alternative Splicing." Clinical & Translational Medicine 13, no. 1 (2023): 1. https://doi.org/10.1002/ctm2.1129.

MLA (9th ed.) Citation

Chen, Qi Wen, et al. "LncRNA BC Promotes Lung Adenocarcinoma Progression by Modulating IMPAD1 Alternative Splicing." Clinical & Translational Medicine, vol. 13, no. 1, 2023, p. 1, https://doi.org/10.1002/ctm2.1129.